Loading…
cbdMD, Inc. is projected to decline to $0.541 by 2027, a -5% move from its current price of $0.5695. YCBD is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/4/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 5 | $0.5486 | $0.5696 | $0.5913 | +0.01% |
| Aug 6 | $0.5402 | $0.5696 | $0.6007 | +0.02% |
| Aug 7 | $0.5338 | $0.5697 | $0.6079 | +0.03% |
| Aug 8 | $0.5285 | $0.5697 | $0.6141 | +0.04% |
| Aug 9 | $0.5239 | $0.5698 | $0.6197 | +0.05% |
| Aug 10 | $0.5198 | $0.5699 | $0.6247 | +0.06% |
| Aug 11 | $0.516 | $0.5699 | $0.6294 | +0.07% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $0.516 | $0.5699 | $0.6294 | +0.07% |
| Week 2 | $0.4956 | $0.5703 | $0.6563 | +0.14% |
| Week 3 | $0.4806 | $0.5707 | $0.6778 | +0.22% |
| Week 4 | $0.4683 | $0.5711 | $0.6966 | +0.29% |
| Week 5 | $0.4578 | $0.5715 | $0.7136 | +0.36% |
| Week 6 | $0.4485 | $0.572 | $0.7294 | +0.43% |
| Week 7 | $0.4401 | $0.5724 | $0.7443 | +0.50% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
cbdMD, Inc. is a healthcare company that produces and distributes cannabidiol (CBD) products in the United States and internationally. It owns and operates consumer hemp-based CBD brands, with the cbdMD brand offering oils, gummies, capsules, soft-gels, topicals, functional formulations, and hemp-derived compliant Delta-9 THC products.
The company also provides products for dogs and cats under the Paw CBD brand, non-cannabinoid functional ingredients under ATRx, and hemp-derived solutions under Herbal Oasis. It serves retailers and health and pet channels through direct-to-consumer, e-commerce platforms, online marketplaces, and wholesale distribution. cbdMD, Inc.
was formerly Level Brands, Inc. and changed its name to cbdMD, Inc. in May 2019. The company is based in Charlotte, North Carolina.
cbdMD, Inc. trades as YCBD and currently has a price of $0.5069 with a market capitalization of $5.32M. It holds a rank of 5262 among listed assets. The current price and market position reflect a small-cap profile within the healthcare/cannabinoid space.
A major floor 54.9% below — a decisive break under it would weaken the trend.
The nearest floor, 17.3% below — buyers have tended to step in here.
The nearest ceiling, 42.2% above — a clean break opens room to run.
A major ceiling 77.3% above — clearing it would confirm fresh momentum.
Key YCBD support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of YCBD market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $0.4974 | Buy | $0.5048 | Buy |
| MA 10 | $0.532 | Buy | $0.5343 | Buy |
| MA 20 | $0.6142 | Sell | $0.5831 | Sell |
| MA 50 | $0.6767 | Sell | $0.6596 | Sell |
| MA 100 | $0.7309 | Sell | $0.7281 | Sell |
| MA 200 | $0.8317 | Sell | $0.9434 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 32.65 | Neutral |
| Stoch RSI (14) | 49.99 | Neutral |
| CCI (20) | -82.51 | Neutral |
| Williams %R (14) | -80.75 | Info |
| MACD (12,26,9) | -0.01 | Sell |
| ROC (12) | -20.78 | Sell |
| Bollinger %B (20,2) | 0.23 | Neutral |
| Stochastic %K (14) | 19.25 | Buy |
| TRIX (15) | -0.97 | Sell |
| Awesome (5,34) | -0.15 | Sell |
| Ultimate (7,14,28) | 24.31 | Buy |
| Momentum (10) | -0.06 | Sell |
| Aroon Osc (25) | -60.00 | Sell |
| Hull MA (9) | 0.47 | Buy |
| ADX (14) | 29.72 | Sell |
| ATR (14) | 0.02 | Info |
Technically, the 30-day picture is bearish with an RSI at 30. The SMA(50) stands at $0.6767 and the SMA(200) at $0.8317, indicating limited near-term upside relative to the longer-term trend. Near-term support sits at $0.471 and resistance at $0.81, framing the front line for price moves.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $0.471 | $0.5695 | $0.6853 | 0% | Neutral | |
| $0.417 | $0.541 | $0.7504 | -5% | Neutral | |
| $0.348 | $0.4702 | $0.6851 | -17% | Bearish | |
| $0.3502 | $0.4895 | $0.7408 | -14% | Neutral | |
| $0.3553 | $0.5117 | $0.7992 | -10% | Neutral | |
| $0.3781 | $0.5599 | $0.8985 | -2% | Neutral | |
| $0.4511 | $0.6853 | $1.13 | +20% | Bullish | |
| $0.4309 | $0.6709 | $1.13 | +18% | Neutral | |
| $0.3773 | $0.6014 | $1.03 | +6% | Neutral | |
| $0.3747 | $0.6109 | $1.07 | +7% | Neutral | |
| $0.4892 | $0.8856 | $1.67 | +56% | Bullish | |
| $0.612 | $1.34 | $2.82 | +135% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $0.471 | $0.5695 | $0.6894 | +0.00% |
| September 2026 | $0.4901 | $0.5857 | $0.724 | +2.85% |
| October 2026 | $0.4764 | $0.5749 | $0.721 | -1.86% |
| November 2026 | $0.4451 | $0.5413 | $0.6869 | -5.83% |
| December 2026 | $0.4363 | $0.5344 | $0.6853 | -1.28% |
Click any year to see its month-by-month YCBD forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, YCBD is projected to trade between $0.471 and $0.6853, averaging $0.5695 — a potential gain of 0% from today's $0.5695. A consolidation phase looks the most probable path here.
cbdMD, Inc.'s 2027 outlook centres on $0.541, within a $0.417 to $0.7504 range. That is -5% versus the projected 2026 average. That marks a -5% change versus current levels. Price action looks broadly range-bound.
By 2028, YCBD could reach as high as $0.6851, with a base case around $0.4702 and support toward $0.348 — roughly -17% from $0.5695. Expect choppier, lower action through this leg of the cycle.
Expect YCBD to range from $0.3502 to $0.7408 through 2029. The $0.4895 average target implies a -14% move from current prices. That is up +4% on the projected 2028 average. Price action looks broadly range-bound.
The YCBD price prediction for 2030 points to an average of $0.5117 (low $0.3553, high $0.7992) — a potential decline of -10% on today's $0.5695. A consolidation phase looks the most probable path here.
In 2031, YCBD is projected to trade between $0.3781 and $0.8985, averaging $0.5599 — a potential decline of -2% from today's $0.5695. That is up +9% on the projected 2030 average. Price action looks broadly range-bound.
cbdMD, Inc.'s 2032 outlook centres on $0.6853, within a $0.4511 to $1.13 range. That is up +22% on the projected 2031 average. That marks a +20% change versus current levels. Buyers look set to stay in control over this stretch.
By 2033, YCBD could reach as high as $1.13, with a base case around $0.6709 and support toward $0.4309 — roughly +18% from $0.5695. Price action looks broadly range-bound.
Expect YCBD to range from $0.3773 to $1.03 through 2034. The $0.6014 average target implies a +6% move from current prices. That is -10% versus the projected 2033 average. A consolidation phase looks the most probable path here.
The YCBD price prediction for 2035 points to an average of $0.6109 (low $0.3747, high $1.07) — a potential gain of +7% on today's $0.5695. Price action looks broadly range-bound.
In 2040, YCBD is projected to trade between $0.4892 and $1.67, averaging $0.8856 — a potential gain of +56% from today's $0.5695. That is up +45% on the projected 2035 average. Buyers look set to stay in control over this stretch.
cbdMD, Inc.'s 2050 outlook centres on $1.34, within a $0.612 to $2.82 range. That is up +51% on the projected 2040 average. That marks a +135% change versus current levels. Momentum favours further upside here.
Investing $1,000 in YCBD today (≈ 1,755.926251 YCBD) could be worth
$2,353.4
+$1,353.4 (+135%) by 2050 · US Dollar
Based on the average projected YCBD price of $1.34 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in YCBDwould be worth at today's price.
$1,000 invested in YCBD on Jul 31, 2025 (≈ 1,114.827183 YCBD) would be worth
$634.89
-$365.11 (-36.5%) today · 0.63× · US Dollar
Based on a YCBD entry price of $0.897 vs. today's $0.5695.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $0.538 | $1,058.55 | +5.9% |
| 1 month ago | $0.68 | $837.5 | -16.3% |
| 3 months ago | $0.87 | $654.6 | -34.5% |
| 6 months ago | $0.869 | $655.35 | -34.5% |
| 1 year ago | $0.897 | $634.89 | -36.5% |
| All time (5.0y) ago | $806.4 | $0.71 | -99.9% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our YCBD forecast.
Our base-case forecast reaches $1.10 around 2050.
Implied market cap at $1.10: $11.55M
The multi-year forecast shows a mixed path with Neutral sentiment through 2026-2031, turning bullish from 2032 onward. For 2030, the average price is $0.4555 with a min of $0.3162 and a max of $0.7114, and a negative ROI of -10.1. By 2040, the average rises to $0.7889 with a positive ROI of 55.6 and a bullish stance.
In 2050, the average is $1.20 with a strong positive ROI of 136 and bullish sentiment. Notably, 2032 shows a bullish signal with an average of $0.6116 and a ROI of 20.7, suggesting a shift in momentum before the later, larger gains. The forecast also indicates high volatility, with annualized volatility at 70%, underscoring substantial uncertainty across the horizon.
Tap a question to reveal the answer.
The forecast shows a min of $0.3162, an avg of $0.4555, and a max of $0.7114 with an ROI of -10.1 and sentiment Neutral.
The forecast conveys Neutral sentiment through 2026-2031 with year-by-year variations, including a Bearish period in 2028 (avg $0.4182, ROI -17.5) and a negative ROI in 2029-2031, before turning bullish in 2032 (avg $0.6116, ROI 20.7). Overall, the outlook shows mixed returns rather than a consistent gain.
Yes. The forecast shows a max of $2.52 by 2050, with the 2050 average at $1.20 and a bullish sentiment.
The current price is $0.5069 and the market cap is $5.32M.
Bullish momentum appears first in 2032, with an average of $0.6116, a max of $1.01, a min of $0.4025, and a ROI of 20.7.
cbdMD, Inc. Community Discussion
0Share your cbdMD, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.